Creative Biolabs is strengthening its lipid-based delivery portfolio with enhanced lipid nanoparticle (LNP) and liposome engineering capabilities designed to support the growing demand for RNA ...

Erga Bitootessa 8, 2026 hoogganaa olaanaa Iraan ta'uun muudamee maqaasaatiin dhimmoota garaagaraa irratti ibsa barreeffamaan ...

Scribe Therapeutics’ pipeline is immature, with its lead program recently greenlit for first-in-human testing. The biotech is working on CRISPR-based therapies for cardiometabolic diseases. Scribe ...

Opinion: Amid record-breaking heat, investing in healthier, more affordable homes is so important, writes Ruth Ann Norton and ...

Chinese drugmaker CSPC Pharmaceutical Group said on Thursday that it had entered a strategic collaboration with AstraZeneca ...

SUZHOU, China and MÖLNDAL, Sweden, July 2, 2026 /PRNewswire/ -- Suzhou Ribo Life Science Co., Ltd. (06938.HK), and its subsidiary Ribocure Pharmaceuticals AB (collectively referred to as "Ribo"), in ...

SUZHOU, China and MÖLNDAL, Sweden, July 2, 2026 /PRNewswire/ -- Suzhou Ribo Life Science Co., Ltd. (06938.HK), and its subsidiary Ribocure Pharmaceuticals AB (collectively referred to as "Ribo"), in ...

Ribocure Pharmaceuticals AB, a subsidiary of Suzhou Ribo Life Science Co. Ltd., and Madrigal Pharmaceuticals Inc. have achieved the first drug candidate nomination within their siRNA partnership.

Global beauty giant L’Oréal signed a contract on June 29 with domestic biotech firm OliX to discover “short interfering ...

THE WHAT? L’Oréal has expanded its research partnership with South Korean biotechnology company OliX, extending their collaboration to include RNA interference (RNAi)-based innovations for nail health ...

Back on June 1, Voyager Therapeutics Inc. (NASDAQ:VYGR) received FDA approval for VY1706, a gene therapy for Alzheimer’s that ...

TheFly reported on June 24 that Cantor Fitzgerald analyst Prakhar Agrawal initiated coverage of SLN with an Overweight rating ...